Human embryonic stem (hES) cells show an atypical cellcycle regulation characterized by a high proliferation rate and a short G1 phase [1, 2] . In fact, a shortened G1 phase might protect ES cells from external signals inducing differentiation, as shown for certain stem cells [3] . It has been suggested that self-renewal and pluripotency are intimately linked to cell-cycle regulation in ES cells [4] [5] [6] , although little is known about the overall importance of the cell-cycle machinery in maintaining ES cell identity. An appealing model to address whether the acquisition of stem cell properties is linked to cell-cycle regulation emerged with the ability to generate induced pluripotent stem (iPS) cells by expression of defined transcription factors [7] [8] [9] [10] [11] . Here, we show that the characteristic cell-cycle signature of hES cells is acquired as an early event in cell reprogramming. We demonstrate that induction of cell proliferation increases reprogramming efficiency, whereas cell-cycle arrest inhibits successful reprogramming. Furthermore, we show that cell-cycle arrest is sufficient to drive hES cells toward irreversible differentiation. Our results establish a link that intertwines the mechanisms of cell-cycle control with the mechanisms underlying the acquisition and maintenance of ES cell identity.
Summary
Human embryonic stem (hES) cells show an atypical cellcycle regulation characterized by a high proliferation rate and a short G1 phase [1, 2] . In fact, a shortened G1 phase might protect ES cells from external signals inducing differentiation, as shown for certain stem cells [3] . It has been suggested that self-renewal and pluripotency are intimately linked to cell-cycle regulation in ES cells [4] [5] [6] , although little is known about the overall importance of the cell-cycle machinery in maintaining ES cell identity. An appealing model to address whether the acquisition of stem cell properties is linked to cell-cycle regulation emerged with the ability to generate induced pluripotent stem (iPS) cells by expression of defined transcription factors [7] [8] [9] [10] [11] . Here, we show that the characteristic cell-cycle signature of hES cells is acquired as an early event in cell reprogramming. We demonstrate that induction of cell proliferation increases reprogramming efficiency, whereas cell-cycle arrest inhibits successful reprogramming. Furthermore, we show that cell-cycle arrest is sufficient to drive hES cells toward irreversible differentiation. Our results establish a link that intertwines the mechanisms of cell-cycle control with the mechanisms underlying the acquisition and maintenance of ES cell identity.
Results

Acquisition of a High Proliferation Rate Is an Early Event in Cell Reprogramming
Human induced pluripotent stem (hiPS) cells are molecularly and functionally similar to human embryonic stem (hES) cells in terms of pluripotent gene expression and the ability to support differentiation into the three embryonic germ layers [7] [8] [9] [10] [11] . In agreement, we have observed that the characteristic cell-cycle structure of hES cells, comprised of a large number of cells in S phase and an abbreviated G1 phase [1, 2] , is also acquired in established hiPS cell lines (see Figure S1 and Supplemental Results available online). Thus, this led us to investigate whether the acquisition of this profile is an early step in the process of reprogramming. To this end, we used keratinocytes, a cell source with high reprogramming efficiency, where nascent iPS cell colonies arise between 10 and 14 days during the reprogramming process [12] . Therefore, we analyzed the cell-cycle profile of emerging iPS cell colonies as identified by the stem cell surface markers Tra-1-81 and Tra-1-60, 12 days after the expression of OCT4, SOX2, KLF4, and cMYC (OSKC) [13] (Figure 1A ). The Tra-1-60 + and Tra-1-81 + populations of cells displayed a cell-cycle profile similar to that observed in hES cells (H9 cell line), in contrast to the Tra-1-60 2 and Tra-1-81 2 populations (Figure 1A) . Next, we also analyzed the level of proliferation, by measuring the percentage of bromodeoxyuridine (BrdU) incorporation in emerging iPS cell colonies that express the stem cell marker Nanog. We determined that the percentage of BrdU + cells in hES and the nascent Nanog + iPS cell colonies was similar and was in contrast to the reduced levels of BrdU + cells observed in the somatic cell of origin ( Figure 1B ). To further evaluate these findings, we developed a cellular assay to identify early hiPS cell colonies based on the expression of a green fluorescent protein (GFP) gene driven by the endogenous OCT4 promoter. It has been shown that reactivation of endogenous pluripotent gene expression is a necessary and early event for successful reprogramming [14] . Therefore, we differentiated a knockin OCT4
GFP human H1 ES cell line [15] GFP cells with OSKC reactivated the expression of the endogenous OCT4 locus, which correlated with the appearance of GFP ( Figure S2B ). Moreover, we determined that emerging GFP + hiPS cell colonies are still not transcriptionally identical to hES cells, in contrast to established GFP + hiPS cell lines, thus suggesting that this population represents iPS cells that are not yet fully mature ( Figure S2C) . In experiments to assess proliferation, we observed a comparable percentage of BrdU + cells in hES cells and early GFP + hiPS cells that was significantly higher than the percentage observed in the parental population ( Figure 1C ). Moreover, we were able to detect highly proliferative GFP + colonies as early as 10 days after transduction with OSKC (Figure 1D) . Finally, we analyzed the percentage of cells positive for phosphohistone H3, a well-defined mitotic marker, to further assess the acquisition of proliferative abilities in emerging hiPS cell colonies. We observed that GFP + colonies derived from dFib-OCT4 GFP cells, as well as Tra-1-60 + colonies derived from keratinocytes, showed a similar percentage of phosphohistone H3
+ cells compared to hES cells, which was significantly higher than the percentages found in the starting cell populations (Figures 1E and 1F) . Collectively, these data strongly suggest that the characteristic proliferative abilities of hES cells are acquired as an early event in the generation of hiPS cells.
Induction of Cell Proliferation Promotes Formation of hiPS Cells, Whereas Cell-Cycle Arrest Inhibits Cell Reprogramming
It has been reported that the expression of OSKC triggers a senescence response and induces a G1 cell-cycle arrest [16] . Cell-cycle progression through G1 to S phase requires the stepwise phosphorylation and functional inactivation of retinoblastoma (pRb), which regulates cell-cycle progression through the binding to and inhibition of E2F transcription *Correspondence: belmonte@salk.edu factors [17] . This phosphorylation is mediated by cyclindependent kinases (CDKs), which require for their activation the binding of cyclins (Cyc) [18] . Therefore, formation of the CycD-CDK4/6 and CycE/A-CDK2 complexes allows progression of cells into S phase. Conversely, cell-cycle arrest is mediated through the expression of CIP/KIP (p21, p57, and p27) and INK4 (p15, p16, p18, and p14) family members of CDK inhibitors (CKIs) [17] [18] [19] [20] . We tested whether overcoming the OSKC-induced cell-cycle arrest in order to establish the hES cell-cycle structure in hiPS cells was an important event during the acquisition of pluripotency. Thus, we investigated whether modulation in the expression of proteins involved in the control of the G1-to-S phase transition, and hence the proliferation status, would affect the efficiency of cell reprogramming. To this end, we designed a panel of lentiviruses encoding short hairpin RNAs against pRb, CDK2/4, CycE1, and CycD1/D2 ( Figure S3A ) and retroviruses encoding different cell-cycle proteins (p15, p16, p21, CycD1/D2, CDK1/2/4, and CycE2) and coinfected them with OSKC in keratinocytes. Downregulation of pRb induced an average 3-fold increase in the efficiency of reprogramming ( Figure 2A ). Interestingly, we observed that no colonies arose from keratinocytes when CycE1 (a CDK2 activator) or CycD2 (a CDK4 activator) was downregulated ( Figure 2A ), whereas no changes in reprogramming efficiency were detected following CDK2, CDK4, or CycD1 downregulation ( Figure 2A ). We also found that ectopic expression of the cell-cycle arrest mediators p15, p16, or p21 resulted in almost no hiPS cell colony formation ( Figure 2B ). Moreover, we observed that expression of CycD1, CycD2, and CycE2, but not CDK1, CDK2, or CDK4, increased reprogramming efficiency up to more than 2-fold compared to controls ( Figure 2C ). Similar results were obtained with either IMR90 or BJ fibroblasts (data not shown).
Next, we hypothesized that the expression of a cyclin together with its CDK catalytic partner, rather than its expression alone, might have a more profound effect on reprogramming efficiency. Indeed, we observed a dramatic increase in reprogramming efficiency, up to 10-fold, by coexpressing CycD1/CDK4 in BJ fibroblasts, a cell type that typically reprograms less efficiently than keratinocytes ( Figure 2D ). Importantly, we observed that changes in cell proliferation correlated perfectly with changes in reprogramming efficiency ( Figures 2E-2G ). Moreover, we further used cumulative BrdU labeling, which provides information about the rate of S phase entry and the length of the cell cycle [21] , to determine that either overexpression of p16, p15, or p21 or downregulation of CycD2 or CycE1 resulted in a permanent cell-cycle arrest in the population of cells subjected to reprogramming. However, overexpression of CycD1, CycE2, or CDK4/CycD1 or downregulation of pRb resulted in a constant increased rate of cells entering into S phase over the time of the analysis compared to control cells ( Figure S3B ). In summary, our results suggest that alleviation of the cell-cycle arrest induced by OSKC, by promoting S phase entry, increases the efficiency of cell reprogramming, whereas a further induction of cellcycle arrest has the opposite effect ( Figures 2E-2G) .
We next examined whether the observed increase in reprogramming efficiency following induced proliferation was due to an acceleration in the rate of reprogramming or to an increase in the number of cells amenable to being reprogrammed. To this end, we infected dFib-OCT4 GFP cells with OSKC alone, OSKC+CycD1, or OSKC+CDK4/CycD1. The appearance of the first GFP + colonies following OSKC expression were detected as early as 8 days after infection ( Figure 2H) . Surprisingly, we did not observe differences in the rate of cell reprogramming upon increasing cell proliferation, as mediated by CycD1 or CycD1/CDK4, because all conditions showed GFP + colonies by day 8 ( Figure 2H ). However, in agreement with our previous findings, we observed many more colonies when CycD1 or CycD1/CDK4 was overexpressed ( Figure 2H ).
Collectively, these data demonstrate that an increase in the proliferation rate induces a burst in the number of cells amenable to being reprogrammed, rather than modifying the kinetics of the reprogramming process.
Cell-Cycle Arrest Is Sufficient to Drive hES Cells toward Irreversible Differentiation
We have shown that acquisition of self-renewal and pluripotency during cell reprogramming is associated with the successful overcoming of the cell-cycle arrest mediated by OSKC and the establishment of the ES cell-cycle structure. Next, we investigated whether self-renewal and pluripotency are dependent on the atypical mode of cell-cycle regulation in hES cells. We generated H9 cell lines harboring doxycycline (dox)-inducible expression constructs for the cell-cycle arrest inducers p15, p16, and p21 to determine whether overexpression of these proteins in hES cells poises them for differentiation by promoting changes in the cell-cycle structure. We detected a significant increase in the percentage of hES cells in G1 phase as early as 24 hr after induction of p15, p16, or p21 expression, with p21 showing the most dramatic effect ( Figures 3A and 3B and data not shown) . The accumulation of cells in G1 phase might indicate that a subpopulation of cells is arresting in G1, but it could also suggest that cells are undergoing a lengthening of G1 phase. To distinguish between these two possibilities, we subjected our inducible hES cell lines to cumulative BrdU labeling. Via this approach, we were able to establish the time spent in the G2, M, and G1 phases (T G2+M+G1 ) (see Supplemental Experimental Procedures for details). We observed that induction of p21 resulted in a permanent cell-cycle arrest ( Figure 3B) Figure 3B ). Next, we assessed the effects of p15-, p16-, or p21-mediated cell-cycle changes on hES self-renewal and pluripotency. Prolonged induction of p21 resulted in massive cell differentiation into nonproliferative cells following 10 days of doxycycline treatment ( Figures 3C-3F ). In contrast, the expression of p15 or p16 resulted in an intermediate phenotype in which highly proliferative hES cell-like colonies were detected but were surrounded by differentiated nonproliferative cells ( Figures  3C and 3D) . We then performed gene expression and protein analysis of pluripotency and differentiation markers in the inducible H9 cell lines maintained in normal growth medium or following 10 days of continuous doxycycline treatment ( Figures 3D-3F and data not shown) . We detected OCT4 expression after overexpression of p15 or p16 in the areas that morphologically resembled hES cells, but not in their surrounding differentiated populations ( Figure 3D ). However, OCT4 expression was lost after continuous p21-induced cellcycle arrest in hES cells (Figures 3D and 3E) . Furthermore, in hES cells where p15, p16, or p21 was induced, we detected elevated expression levels of several differentiation markers, which was not observed in the control GFP line or in the same lines not treated with doxycycline ( Figure 3F and data not shown).
Next, we investigated whether the cell-cycle-induced differentiation in hES cells is reversible. We also evaluated the minimum duration of cell-cycle inhibitor expression required to trigger differentiation. To this end, we analyzed the morphology as well as the expression of differentiation markers in cells where p21 expression was induced by adding doxycycline to the medium for the indicated number of days followed by its withdrawal at each indicated time point and culturing for a total of 10 days ( Figure 4A ). Interestingly, we observed that only 1 day of p21 induction resulted in cultures where morphologically hES-like cells were surrounded by differentiated cells (Figures 4B and 4C) . We also determined that 3 days of continuous p21 induction was enough to trigger massive differentiation, and that withdrawal of doxycycline was not sufficient to rescue the differentiation phenotype ( Figures 4B-4D) . Consequently, continuous induction of p21 expression for more than 3 days resulted in stronger expression of several differentiation markers ( Figure 4D ). In contrast, we did not observe any morphological changes and/or expression of differentiation markers after inducing expression of GFP (data not shown). Taken together, these data suggest that differentiation induced by cell-cycle arrest in hES cells is an irreversible process.
Discussion
Our data establish an essential role for cell proliferation in both cell reprogramming and the maintenance of self-renewal and pluripotency in hES cells. We showed that alteration in the rate of hES cell proliferation leads to a compromise in the maintenance of self-renewal and pluripotency. In fact, we observed that expression of p15 or p16 in hES cells induces a lengthening of the average time spent in the G2, M, and G1 phases that correlates with an increased propensity to differentiate. The lengthening presumably affects the G1 phase, given the fact that both p15 and p16 are well-known cell-cycle inhibitors of G1 CDKs [17] [18] [19] [20] . Interestingly, it has been proposed that the length of the G1 phase may influence the fate of stem cells and is a determinant in stem cell differentiation [3, [22] [23] [24] .
We also demonstrated that induction of cell-cycle arrest is sufficient to commit hES cells toward differentiation.
Surprisingly, we were able to obtain differentiated cells when culturing the cell-cycle-arrested cells in mTeSR1, a chemically defined feeder-free hES cell medium [25] . We further observed that the differentiation triggered by inducing cell-cycle arrest in hES cells is an irreversible process. In fact, 3 days of cell-cycle arrest was sufficient to commit hES cells toward differentiation. These results suggest that hES cells are specified to (C) Immunofluorescence analysis of the differentiation markers for the mesodermal (SMA), trophectodermal (Cdx2), ectodermal (Tuj1), and endodermal (AFP, albumin, and FoxA2) germ layers in the p21-inducible H9 cell line after 3 days of induction with 200 ng/ml doxycycline followed by 7 days of continued culture after its withdrawal. Scale bars represent 100 mm. (D) Real-time PCR analysis of the pluripotency marker OCT4 and the specific differentiation markers for mesodermal (Msx1), trophectodermal (Cdx2), ectodermal (Pax6 and FGF5), and endodermal (GATA4, GATA6, AFP, albumin, and FoxA2) germ layers in the p21-inducible H9 cell line after the induction conditions indicated. Data are shown as relative averages 6 SD of two biological replicates analyzed in triplicate. maintain a high proliferation rate in order to support their selfrenewal. In fact, whereas the expression of p15 or p16 in somatic cells, such as keratinocytes, induced a complete cell-cycle arrest, the expression of the same proteins in hES cells still enabled proliferation to occur despite causing alterations to the cell-cycle structure. Moreover, we observed that the cell-cycle properties found in hES cells are acquired early in the process of cell reprogramming. Overcoming the cell-cycle arrest induced by OSKC expression might be an early and necessary event for successful reprogramming [16] . In fact, it has been reported that silencing of the Ink4/ Arf locus occurs early in cell reprogramming [26] . Moreover, OCT4 is able to inhibit the expression of the p21 promoter [6] . In agreement, as early as day 10 days after infection of dFib-OCT4 GFP cells, we detected highly proliferative small colonies in which the endogenous pluripotent network was already reactivated ( Figure 1D) .
Finally, we showed that stimulation of cell proliferation improves somatic cell reprogramming, whereas the induction of cell-cycle arrest impairs this process. Indeed, some of the first genetic events during cell reprogramming are the inactivation of the p53/p21 pathway [27] [28] [29] and the Ink4/Arf locus [26] . Our results establish a perfect correlation between the stimulation or the inhibition of cell proliferation and the efficiency of cell reprogramming. Interestingly, we observed that expression of different CDKs, such as CDK4 or CDK2, neither modified the percentage of cells in S phase nor impacted the reprogramming efficiency. Conversely, the expression of their corresponding activators, CycD1/D2 or CycE2 respectively, positively increased both processes. This can be explained by the fact that cyclins are the limiting factor in inducing CDK activity and promoting entry into S phase. Consequently, coexpression of CycD1/CDK4 induced a higher accumulation of cells in S phase and increased reprogramming efficiency up to 10-fold. However, we did not observe variation in the efficiency of reprogramming after the coexpression of CycE/CDK2, which correlated with the absence of a change in proliferation status in cells subjected to reprogramming (data not shown). Nonetheless, the exact mechanisms by which cell division affects reprogramming efficiency are unknown. It is possible that active promotion of transition through S phase might enable epigenetic resetting of the genome and/or promote proliferation to increase the number of cells available for stochastic reprogramming.
Overall, we have demonstrated that self-renewal and pluripotency rely on the particular cell-cycle regulation observed in hES cells. Consequently, we show that a high proliferation rate is a requirement for the acquisition and maintenance of pluripotency and self-renewal of hES and hiPS cells. In summary, we provide strong evidence showing that cell-cycle regulatory pathways and the pluripotency network are intricately connected to safeguard ES cell identity.
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